When was Lattice Medical founded?

Lattice Medical was founded in 2017 and raised its 1st funding round 5 years after it was founded.

Where is Lattice Medical located?

Lattice Medical is headquartered in Loos, France.

Who is the current CEO of Lattice Medical?

Julien Payen of Lattice Medical. They have also founded 1 company.

How many employees does Lattice Medical have?

As of Jun 30, 2026, the latest employee count at Lattice Medical is 40.

Is Lattice Medical a funded company?

Lattice Medical is a funded company, having raised a total of $63.4M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jan 17, 2022.

When was the latest funding round of Lattice Medical?

Lattice Medical's latest funding was a $***** Grant (prize money) round on Oct 29, 2025, with participation from 1 investor.

Where does Lattice Medical rank among its competitors?

Lattice Medical ranks 6th amongst 66 active competitors, of which 17 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was CTIBiotech, which secured $1.47M in Apr, 2026.

Who are the top competitors of Lattice Medical?

Lattice Medical's top competitors include Establishment Labs, GC Aesthetics and Sientra. Among them, CTIBiotech secured the most recent funding round in April, 2026.

Lattice Medical - 2026 Company Profile, Team, Funding & Competitors

Lattice Medical is a series B company based in Loos (France), founded in 2017 by Julien Payen. It operates as a Provider of 3D-printed technology for soft tissue reconstruction. Lattice Medical has raised $63.4M in funding from investors like WiSEED, Finovam Gestion and Bpifrance. The company has 66 active competitors, including 17 funded and 12 that have exited. Its top competitors include companies like Establishment Labs, GC Aesthetics and Sientra.

Company Details

Provider of 3D-printed technology for soft tissue reconstruction. It also provides the solution for tissue engineering and regenerative medicine by using its propriety 3D-printed bioresorbable scaffold technology and adipose tissue to naturally regenerate. The technology is used for a personalized implant like for breast reconstruction and augmentation among others.

Website: www.lattice-medical.com/
Social
Email ID: *****@lattice-medical.com

Key Metrics

Founded Year

2017

Location

Loos, France

Stage

Series B

Total Funding

$63.4M in 5 rounds

Latest Funding Round

Grant (prize money), Oct 29, 2025, $*****

Investors

WiSEED & 9 more

Ranked

6^th among 66 active competitors

Employee Count

40 as on Jun 30, 2026

Similar Companies

Establishment Labs & 81 more

View Lattice Medical's full profile

Lattice Medical has raised a total funding of $63.4M over 5 rounds. Its first funding round was on Jan 17, 2022. Its latest funding round was a Grant (prize money) round on Oct 29, 2025 for $*****. 1 investor participated in its latest round. Lattice Medical has 10 institutional investors.

Here is the list of recent funding rounds of Lattice Medical:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 29, 2025	1877492	Grant (prize money)	9519106	4968829	2707914	8291424
Oct 23, 2025	3754235	Series B	3879275	4786493	6504248	Blast.Club & 5 more
Oct 01, 2022	9872407	Series A	6161447	3344623	Finovam Gestion & 2 more	1530415

Access funding benchmarks and valuations. Sign up today!

View details of Lattice Medical's funding rounds and investors

The founders of Lattice Medical is Julien Payen. Julien Payen is the CEO of Lattice Medical.

Here are the details of Lattice Medical's key team members:

Julien Payen: Co-Founder & CEO of Lattice Medical.
Contact Info: 1 email address

View details of Lattice Medical's Founder profiles and Board Members

Lattice Medical's employee count trend

Lattice Medical has 40 employees as of Jun 26. Here is Lattice Medical's employee count trend over the years:

Employee count trend for Lattice Medical

Uncover Lattice Medical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Lattice Medical include Establishment Labs, GC Aesthetics and Sientra. Here is the list of Top 10 competitors of Lattice Medical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Establishment Labs 2010, Alajuela (Costa Rica), Public	Developer of silicone-filled breast and body shaping implants	$121M	Perceptive Advisors, Crown Predator Holdings ... & 7 others	70/100
2nd	GC Aesthetics 2007, Dublin (Ireland), Series E	Manufacturer of silicone breast implants for aesthetic and reconstructive surgery	$233M	Montreux Equity Partners, Barry’s Tea & 18 others	60/100
3rd	Sientra 2007, Santa Barbara (United States), Public	Products for plastic surgery/ aesthetics	$150M	Goldman Sachs, Deerfield & 4 others	53/100
4th	Shibuya Kogyo 1931, Kanazawa (Japan), Public	Technology for biological 3D printing	-	Nagoya Small and Medium Business Investment & Consultation ... Read more	53/100
5th	Healshape 2020, Villeurbanne (France), Series A	Developer of products for breast reconstruction and augmentation	$12.8M	Bpifrance, Demeter & 4 others	51/100
6th	Lattice Medical 2017, Loos (France), Series B	Provider of 3D-printed technology for soft tissue reconstruction	$63.4M	Bpifrance, ANR & 8 others	49/100
7th	3D Bio Corporation 2014, New York City (United States), Series A	3D Bio-printed living tissues	$5.03M	Kairos Ventures, Blue Collective & 9 others	48/100
8th	Dimension Inx 2017, Chicago (United States), Series A	Provider of 3D bio materials for regenerative medicine	$17.6M	Prime Movers Lab, KdT Ventures & 11 others	47/100
9th	CTIBiotech 2009, Lyon (France), Funding Raised	Develops 3D human tissue models	-	Bpifrance, Government of France	46/100
10th	Prellis Biologics 2016, San Francisco (United States), Series C	Provider of 3D bioprinting technology to build human tissues for drug development	$70.1M	Celesta Capital, Khosla Ventures & 12 others	46/100